Chief Business Officer, Companion Diagnostics, Agilent Technologies
Biography
Trevor Page is currently the chief business officer of Agilent's companion diagnostic (CDx) division where he leads the business development and alliance management team responsible for establishing and maintaining CDx development partnerships with pharma and biotech. Over the past 10 years, Trevor helped to vitalize and grow Dako's companion diagnostic program into the Agilent CDx division it is today (Dako is now a subsidiary of Agilent). During this tenure, Trevor formed specific business development and alliance management functions as well as innovated partnering models to help successfully navigate the complex, dynamic and evolving nature of CDx collaborations.
Session Abstract – PMWC 2020 Silicon Valley
Track 4 - January 23 11.30 A.M.-12.00 P.M.
Integrating real-world evidence in all phases of development allows moving from discovery into viable companion diagnostics. However, it doesn’t stop with access; the quality and quantity of RWE data contributes far more complexity. This panel will discuss the promise and challenges in the accelerated time to market for fit-for-patient diagnostics using RWE data.
